Inventor
HEYWOOD SAM PHILIP
GB26 patents
⚠️ This page may combine multiple inventors who share the name “HEYWOOD SAM PHILIP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB BIOPHARMA SPRL
8 patentsUS9873735B2Jan 23, 2018
Method of treatment with antibodies having specificity for human OX40
UCB BIOPHARMA SPRL12 citations83
US9803004B2Oct 31, 2017
Albumin binding antibodies and binding fragments thereof
UCB BIOPHARMA SPRL10 citations83
US10457748B2Oct 29, 2019
Single linker FabFv antibodies and methods of producing same
UCB BIOPHARMA SPRL3 citations72
US10023631B2Jul 17, 2018
Albumin binding antibodies and binding fragments thereof
UCB BIOPHARMA SPRL3 citations72
US10829565B2Nov 10, 2020
Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species
UCB BIOPHARMA SPRL5 citations68
US10828366B2Nov 10, 2020
Method of monomerisation of recombinant antibody molecules
UCB BIOPHARMA SPRL4 citations68
US11466076B2Oct 11, 2022
Binding domain or antibody specific to a human serum albumin (HSA)
UCB BIOPHARMA SPRL0 citations62
US11401349B2Aug 2, 2022
Single linker FabFv antibodies and methods of producing same
UCB BIOPHARMA SPRL0 citations62
UCB Biopharma SRL
8 patentsUS12428497B2Sep 30, 2025
Multispecific antibody constructs
UCB Biopharma SRL0 citations61
US11345760B2May 31, 2022
Multispecific antibody constructs
UCB Biopharma SRL1 citations61
US11091542B2Aug 17, 2021
Antibody molecules which bind TNF alpha
UCB Biopharma SRL0 citations61
US12516106B2Jan 6, 2026
Method for protein purification
UCB Biopharma SRL0 citations60
US10927164B2Feb 23, 2021
Method for protein purification
UCB Biopharma SRL1 citations60
US11834514B2Dec 5, 2023
Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species
UCB Biopharma SRL0 citations58
US11786593B2Oct 17, 2023
Method of monomerisation of recombinant antibody molecules
UCB Biopharma SRL0 citations58
US12570738B2Mar 10, 2026
Multi-specific antibody with binding specificity for human IL-13 and IL-17
UCB Biopharma SRL0 citations53
UCB PHARMA SA
7 patentsUS9309327B2Apr 12, 2016
Dual specificity antibody fusions
UCB PHARMA SA32 citations96
US9040048B2May 26, 2015
Antibody molecules having specificity for human OX40
UCB PHARMA SA19 citations92
US8378073B2Feb 19, 2013
Process for attaching effector molecules to proteins
UCB PHARMA SA10 citations84
US10100130B2Oct 16, 2018
Dual specificity antibody fusions
UCB PHARMA SA5 citations83
US9828438B2Nov 28, 2017
Dual specificity antibody fusions
UCB PHARMA SA7 citations83
US7989594B2Aug 2, 2011
Modified antibody fab fragments
UCB PHARMA SA5 citations63
US11427650B2Aug 30, 2022
Dual specificity antibody fusions
UCB PHARMA SA0 citations61